16:38:23 EDT Thu 22 Oct 2026
Enter Symbol
or Name
USA
CA



Telyrx Holdings Inc
Symbol TELY
Shares Issued 26,798,005
Close 2026-10-21 C$ 2.50
Market Cap C$ 66,995,013
Recent Sedar+ Documents

Telyrx Holdings to release Q3 results Nov. 5

2026-10-22 13:55 ET - News Release

Mr. Neil Weber reports

TELYRX TO HOST THIRD QUARTER 2026 FINANCIAL RESULTS CONFERENCE CALL ON FRIDAY, NOVEMBER 6, 2026 AT 8:30 AM ET

Telyrx Holdings Inc. will host a conference call and webcast to discuss its third quarter 2026 financial results on Friday, Nov. 6, 2026, at 8:30 a.m. Eastern Time. The company expects to report its third quarter 2026 financial results for the period ended Sept. 30, 2026, by news release after market close on Thursday, Nov. 5, 2026.

Telephone dial-in access information

The company will host a conference call to discuss its third quarter 2026 financial results on Friday, Nov. 6, 2026, at 8:30 a.m. Eastern Time. To dial direct and enter the call through an operator, dial 1-833-752-3490 or 1-647-260-0811. The live webcast can be accessed on-line. Please connect approximately 15 minutes prior to the beginning of the webcast or call to ensure participation.

About Telyrx Holdings Inc.

Telyrx is an integrated digital health care platform that makes everyday prescription medications easier to access. Patients connect with independent, state-licensed health care providers who evaluate their needs and prescribe treatment when appropriate. Prescriptions are filled by Telyrx's licensed pharmacies and delivered directly to patients' doors. Serving patients across 48 U.S. states and all territories, Telyrx provides access to more than 500 common, FDA-approved medications for over 60 common health conditions through a seamless, convenient experience.

© 2026 Canjex Publishing Ltd. All rights reserved.